Akso Health Group (AHG)
0.7855
-0.05
(-6.50%)
USD |
NASDAQ |
Apr 24, 16:00
0.7855
0.00 (0.00%)
After-Hours: 20:00
Akso Health Group Cash from Financing (TTM): 0.35M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.35M |
| March 31, 2023 | -27.51M |
| Date | Value |
|---|---|
| September 30, 2022 | -2.073M |
| March 31, 2022 | 34.78M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-27.51M
Minimum
Mar 2023
34.78M
Maximum
Mar 2022
1.386M
Average
-0.8615M
Median
Cash from Financing (TTM) Benchmarks
| Universe Pharmaceuticals Inc | -1.391M |
| Sinovac Biotech Ltd | -- |
| CASI Pharmaceuticals Inc | -- |
| Zai Lab Ltd | -6.433M |
| I-MAB | -- |